Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin-15 is a transmembrane glycoprotein member of the cadherin superfamily, mediating calcium-dependent homophilic cell-cell adhesion, predominantly in muscle cells. The molecule has five extracellular cadherin domains, a single transmembrane domain, and a conserved cytoplasmic tail. Expression is strongest during muscle cell differentiation (myogenesis) and is essential for regulating terminal differentiation in muscle tissue. CDH15's loss or mutation is associated with intellectual disability syndromes, and it participates in cell junction organization and ERK signaling. While it is considered an important receptor-like adhesion molecule, no direct pharmacological modulators are clinically approved.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin-15 (CDH15).